Preclinical Risk Assessment of Plant Lectins with Pharmacological Applications: A Narrative Review
Molecules · 23.12.2025 · 31 (1) · 55
DOI: 10.3390/molecules31010055 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 23.12.2025. Verfasst von Amanda de Oliveira Marinho und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Bioquímica, Centro de Biociências, Universidade Federal de Pernambuco, Recife 50670-901, Brazil. Hauptthemen laut MEDLINE: Plant Lectins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Ciência e Tecnologia de Pernambuco, National Council for Scientific and Technological Development, Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco.
Abstract (Originalsprache)
Plants have been used for medicinal purposes both intuitively and based on traditional knowledge for centuries. Recently, however, there has been a significant increase in research focused on medicinal plants to meet the growing demands of the pharmaceutical industry. As a result, it has become essential to evaluate the safety of natural products for human use. This review examines in vitro and in vivo toxicity studies of lectins, a class of plant proteins with pharmacological applications. The reviewed data indicate that many of these proteins do not appear to be toxic to human and animal cells, nor when administered to rodents through oral, intraperitoneal, or intravenous routes. However, some lectins have shown toxicity under certain conditions, such as depending on the administration route, dose, and treatment duration. These adverse effects may include behavioral changes, antinutritional effects, hepatotoxicity, nephrotoxicity, pancreatic hypertrophy, allergic reactions, and even death. Therefore, it is crucial to prioritize toxicological studies to ensure the safety of these plant proteins as potential drug candidates in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Bioquímica, Centro de Biociências, Universidade Federal de Pernambuco, Recife 50670-901, Brazil.
- Departamento de Bioquímica e Farmacologia, Centro de Ciências da Saúde, Universidade Federal do Piauí, Teresina 64001-020, Brazil.
- Departamento de Morfologia e Fisiologia Animal, Universidade Federal Rural de Pernambuco, Recife 52171-900, Brazil.
ORCID-Profile: Amanda de Oliveira Marinho, Jainaldo Alves da Costa, Emmanuel Viana Pontual, Leydianne Leite de Siqueira Patriota, Thiago Henrique Napoleão
Förderung
- Fundação de Amparo à Ciência e Tecnologia de Pernambuco
- National Council for Scientific and Technological Development
- Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Marinho, A. O., da Silva, M. N. B., da Silva, S. P., Nova, I. C. V., Costa, J. A. D., Paiva, P. M. G., de Albuquerque, L. P., Pontual, E. V., Patriota, L. L. S., & Napoleão, T. H. (2025). Preclinical Risk Assessment of Plant Lectins with Pharmacological Applications: A Narrative Review. Molecules, 31(1), 55. https://doi.org/10.3390/molecules31010055
Vancouver
Marinho AO, da Silva MNB, da Silva SP, Nova ICV, Costa JAD, Paiva PMG, et al. Preclinical Risk Assessment of Plant Lectins with Pharmacological Applications: A Narrative Review. Molecules. 2025;31(1):55. doi:10.3390/molecules31010055
BibTeX
@article{Marinho2025,
author = {Marinho, Amanda de Oliveira and da Silva, Maria Nívea Bezerra and da Silva, Suéllen Pedrosa and Nova, Isabella Coimbra Vila and Costa, Jainaldo Alves da and Paiva, Patrícia Maria Guedes and de Albuquerque, Lidiane Pereira and Pontual, Emmanuel Viana and Patriota, Leydianne Leite de Siqueira and Napoleão, Thiago Henrique},
title = {Preclinical Risk Assessment of Plant Lectins with Pharmacological Applications: A Narrative Review},
journal = {Molecules},
year = {2025},
volume = {31},
number = {1},
pages = {55},
doi = {10.3390/molecules31010055}
}
EUVIMED